Glassman Wealth Services Vertex Pharmaceuticals Inc Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $1,372 - $1,642	4 Added 1.16%	349 $142,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $676 - $724	2 Added 0.58%	345 $119,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $314 - $351	1 Added 0.29%	343 $120,000
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $9,629 - $10,985	34 Added 11.04%	342 $107,000
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $3,143 - $3,536	11 Added 3.7%	308 $88,000
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $4,655 - $5,194	17 Added 6.07%	297 $86,000
Q2 2022 Aug 04, 2022	BUY	$234.96 - $292.55 $11,043 - $13,749	47 Added 20.17%	280 $79,000
Q1 2022 Aug 23, 2022	BUY	$221.42 - $260.97 $3,542 - $4,175	16 Added 7.37%	233 $61,000
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $24,577 - $28,967	-111 Reduced 33.84%	217 $57,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $38,588 - $48,712	218 Added 198.18%	328 $72,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $1,813 - $2,029	10 Added 10.0%	110 $20,000
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $1,499 - $1,768	-8 Reduced 7.41%	100 $20,000
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $3,726 - $4,343	18 Added 20.0%	108 $23,000
Q4 2020 Feb 04, 2021	SELL	$207.01 - $276.09 $16,974 - $22,639	-82 Reduced 47.67%	90 $21,000
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $12,271 - $14,548	48 Added 38.71%	172 $47,000
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $7,440 - $9,761	33 Added 36.26%	124 $36,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $3,396 - $4,212	-17 Reduced 15.74%	91 $22,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $500 - $671	3 Added 2.86%	108 $24,000
Q3 2019 Nov 01, 2019	BUY	$166.23 - $187.09 $2,992 - $3,367	18 Added 20.69%	105 $18,000
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $1,481 - $1,713	-9 Reduced 9.38%	87 $16,000
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $10,806 - $12,850	66 Added 220.0%	96 $18,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $503 - $578	-3 Reduced 9.09%	30 $6,000
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $728 - $849	5 Added 17.86%	33 $6,000
Q4 2017 Feb 06, 2018	BUY	$137.28 - $155.55 $411 - $466	3 Added 12.0%	28 $4,000
Q2 2017 Aug 09, 2017	BUY	N/A	25	25 $3,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.6 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.32 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.05 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account